crc press - E-Lib FK UWKS

The Tat-Derived Cell-Penetrating Peptide 19
8. Wagner, E. et al., Transferrin-polycation conjugates as carriers for DNA uptake into
cells, Proc. Natl. Acad. Sci. USA, 87, 3410–3414, 1990.
9. Curiel, D.T., High-efficiency gene transfer mediated by adenovirus-polylysine-DNA
complexes, Ann. NY Acad. Sci., 716, 36–56, 1994.
10. Dayton, A.I. et al., The trans-activator gene of the human T cell lymphotropic virus
type III is required for replication, Cell, 44, 941–947, 1986.
11. Jeang, K.T., Xiao, H., and Rich, E.A., Multifaceted activities of the HIV-1 transactivator
of transcription, Tat, J. Biol. Chem., 274, 28837–28840, 1999.
12. Frankel, A.D. and Pabo, C.O., Cellular uptake of the Tat protein from human immunodeficiency
virus, Cell, 55, 1189–1193, 1988.
13. Green, M. and Loewenstein, P.M., Autonomous functional domains of chemically
synthesized human immunodeficiency virus Tat trans-activator protein, Cell, 55,
1179–1188, 1988.
14. Fawell, S. et al., Tat-mediated delivery of heterologous proteins into cells, Proc. Natl.
Acad. Sci. USA, 91, 664–668, 1994.
15. Anderson, D.C. et al., Tumor cell retention of antibody Fab fragments is enhanced
by an attached HIV Tat protein-derived peptide, Biochem. Biophys. Res. Commun.,
194, 876–884, 1993.
16. Chen, L.L. et al., Increased cellular uptake of the human immunodeficiency virus-1
Tat protein after modification with biotin, Anal. Biochem., 227, 168–175, 1995.
17. Derossi, D. et al., Cell internalization of the third helix of the Antennapedia homeodomain
is receptor-independent, J. Biol. Chem., 271, 18188–18193, 1996.
18. Derossi, D. et al., The third helix of the Antennapedia homeodomain translocates
through biological membranes, J. Biol. Chem., 269, 10444–10450, 1994.
19. Sabatier, J.-M. et al., Evidence for neurotoxic activity of tat from human immunodeficiency
virus type 1, J. Virol., 65, 961–967, 1991.
20. Perez, A. et al., Evaluation of HIV-1 Tat induced neurotoxicity in rat cortical cell
culture, J. Neurovirol., 7, 1–10, 2001.
21. Loret, E.P. et al., Activating region of HIV-1 Tat protein: vacuum UV circular dichroism
and energy minimization, Biochemistry, 30, 6013–6023, 1991.
22. Ruben, S. et al., Structural and functional characterization of human immunodeficiency
virus tat protein, J. Virol., 63, 1–8, 1989.
23. Vivès, E., Brodin, P., and Lebleu, B., A truncated HIV-1 Tat protein basic domain
rapidly translocates through the plasma membrane and accumulates in the cell
nucleus, J. Biol. Chem., 272, 16010–16017, 1997.
24. Vivès, E. and Lebleu, B., Selective coupling of a highly basic peptide to an oligonucleotide,
Tetrahedron Lett., 38, 1183–1186, 1997.
25. Feener, E.P., Shen, W.C., and Ryser, H.J., Cleavage of disulfide bonds in endocytosed
macromolecules. A processing not associated with lysosomes or endosomes, J. Biol.
Chem., 265, 18780–18785, 1990.
26. Leonetti, J.P. et al., Intracellular distribution of microinjected antisense oligonucleotides,
Proc. Natl. Acad. Sci. USA, 88, 2702–2706, 1991.
27. Hughes, J. et al., In vitro transport and delivery of antisense oligonucleotides, Methods
Enzymol., 313, 342–358, 2000.
28. Astriab–Fisher, A. et al., Antisense inhibition of P-glycoprotein expression using
peptide-oligonucleotide conjugates, Biochem. Pharmacol., 60, 83–90, 2000.
29. Alahari, S.K. et al., Inhibition of expression of the multidrug resistance-associated
P-glycoprotein by phosphorothioate and 5′ cholesterol-conjugated phosphorothioate
antisense oligonucleotides, Mol. Pharmacol., 50, 808–819, 1996.